Clinical Trial Update: Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS [NA]

View source ↗

Summary

Clinical trial investigating whole genome sequencing (ChromoSeq) as an adjunct to conventional genomic profiling in acute myeloid leukemia and myelodysplastic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Washington University School of Medicine | Conditions: Whole Genome Sequencing, Acute Myeloid Leukemia | NA | Status: RECRUITING